Literature DB >> 14688827

HCV and HGV infection in Hodgkin's disease.

Katalin Keresztes1, Mária Takács, Margit Horányi, Zsófia Miltényi, Arpád Illés.   

Abstract

Numerous observations imply that the pathogenesis of malignant lymphomas is multifactorial and that viruses probably play an important etiologic role. Besides Epstein-Barr virus, there might be other viruses among the causes of Hodgkin's disease. A total of 111 randomly selected patients with Hodgkin's disease were included in this study, and hepatitis C and G viruses were tested with polymerase chain reaction. The results were compared to hepatitis C and G virus infection ratios assessed by polymerase chain reaction in the Hungarian blood bank. Hepatitis C virus was diagnosed in 10 (9%) patients, and hepatitis G virus in 9 (8,1%), which is a 12-fold and a 1,5-fold infection rate as compared to that of the Hungarian blood bank, respectively. There was no significant difference between hepatitis positive and negative patients concerning mean age at the time of diagnosis, sex, disease stage, histology type, treatment applied, risk factors in the history of the infection and liver enzymes. Hepatitis C virus positivity in patients with Hodgkin's disease differs significantly from that in blood donors. Based on these results and data in the literature, no definite statement can be made on the etiological role of viruses, but further studies are needed.

Entities:  

Mesh:

Year:  2003        PMID: 14688827     DOI: 10.1007/BF02893381

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  14 in total

Review 1.  Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease.

Authors:  R F Jarrett; J MacKenzie
Journal:  Semin Hematol       Date:  1999-07       Impact factor: 3.851

2.  Hepatitis C virus infection associated with B-cell non-Hodgkin's lymphoma in Hungarian patients.

Authors:  B Gasztonyi; A Pár; A Szomor; I Battyány; A Nagy; L Kereskai; H Losonczy; G Mózsik
Journal:  Br J Haematol       Date:  2000-08       Impact factor: 6.998

3.  Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign?

Authors:  A Cividini; C Rebucci; E Silini; M U Mondelli
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

4.  Hepatitis G virus in patients with Hodgkin's lymphoma.

Authors:  M Persico; A De Renzo; E Persico; R Notaro; R Torella; B Rotoli
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

Review 5.  Hepatitis C virus and non-Hodgkin's lymphomas.

Authors:  G Pozzato; C Mazzaro; G Santini; O Burrone
Journal:  Leuk Lymphoma       Date:  1996-06

Review 6.  [Hepatitis C virus antibody in the serum of blood donors].

Authors:  T K Barna; Z Ozsvár; V Szendrényi; G Gál
Journal:  Orv Hetil       Date:  1996-03-10       Impact factor: 0.540

Review 7.  GB virus C/hepatitis G virus.

Authors:  R Halasz; O Weiland; M Sällberg
Journal:  Scand J Infect Dis       Date:  2001

8.  Hepatitis G virus (HGV) and lymphoproliferative disorders.

Authors:  R D Keenan; P Harrison; L Joffre; S J Skidmore; K E Collingham; D Pillay; D W Milligan
Journal:  Br J Haematol       Date:  1997-12       Impact factor: 6.998

Review 9.  [Interferon therapy of chronic viral hepatitis in Hungary: 5-year experience. A multicenter study].

Authors:  A Pár; L Telegdy; A Gógl; E Müller
Journal:  Orv Hetil       Date:  1999-05-30       Impact factor: 0.540

10.  Characterization of nucleotide sequences from European hepatitis C virus isolates.

Authors:  K Fuchs; M Motz; E Schreier; R Zachoval; F Deinhardt; M Roggendorf
Journal:  Gene       Date:  1991-07-22       Impact factor: 3.688

View more
  3 in total

Review 1.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

2.  Human Hepegivirus-1: Innocent Traveler, Helpful Symbiote, or Insidious Pathogen?

Authors:  Abraham J Kandathil; Ashwin Balagopal
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

3.  Prevalence of Hepatitis C virus Genotype 3a in patients with Hodgkin and Non-Hodgkin Lymphoma.

Authors:  Hashem Radmehr; Manoochehr Makvandi; Alireza Samarbafzadeh; Ali Teimoori; Niloofar Neisi; Mojtaba Rasti; Sara Abasifar; Hasan Soltani; Samaneh Abbasi; Hadis Kiani; Hamide Mehravaran; Azarakhsh Azaran; Toran Shahani
Journal:  Iran J Microbiol       Date:  2016-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.